Worldwide Study on Field Trials of Biotechnological Crops
Author Information
Author(s): Ricroch Agnès, Desachy Louie-David, Penfornis Mateo, Akin Melekşen, Kondić-Špika Ankica, Kuntz Marcel, Miladinović Dragana
Primary Institution: Laboratoire Institut Droit, Espaces et Technologies (IDEST), Faculté Jean Monnet, Université Paris-Saclay
Hypothesis
What are the current trends and regulatory challenges in field trials of biotechnological crops worldwide?
Conclusion
Field trials of biotech crops are crucial for commercialization, but regulatory hurdles vary significantly across countries.
Supporting Evidence
- Field trials are essential for the commercialization of biotech crops.
- Regulatory policies significantly influence the acceptance of field trials.
- Only 41 out of 141 countries with biotech research are currently conducting field trials.
Takeaway
This study looks at how different countries are testing new biotech crops in fields and why some countries are more open to it than others.
Methodology
The study compiled data from a survey of 55 countries and intergovernmental databases regarding field trials of biotech crops.
Potential Biases
Potential bias due to reliance on self-reported data from researchers and varying levels of transparency in different countries.
Limitations
Data could not be obtained for some countries, limiting the comprehensiveness of the study.
Participant Demographics
Researchers from 55 countries involved in biotech plant research.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website